Jefferies downgraded PeptiDream to Hold from Buy with a price target of 1,900 yen, down from 2,200 yen. The firm has become “more optimistic” about radiopharma revenues, but “less optimistic” about margins, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>